[1]
K. Fuhrmann, R. Winn, P. McKenzie, and M. Bashir, “Ceftaroline in the treatment of methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus bacteremia and infective endocarditis in end-stage renal disease”, The Chronicles, vol. 1, no. 4, pp. 53-56, Sep. 2013.